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Neurotrophic factors stimulate survival and
growth of neurons during development and are
involved in the regulation of neuronal survival,
plasticity and regeneration in the adult nervous
system. These growth factors offer an avenue to
develop effective therapy for disorders associ-
ated with degeneration and neuron loss. Earlier
studies showed that nerve growth factor (NGF)
protects basal forebrain cholinergic neurons
from lesion-induced degeneration and stimulates
acetylcholine synthesis and release by surviving
cholinergic neurons. Cell culture studies re-
vealed that brain-derived neurotrophic factor
(BDNF) promotes the developmental differen-
tiation of both basal forebrain cholinergic and
mesencephalic dopaminergic neurons. However,
in adult rats, BDNF was less potent and less
effective than NGF in protecting forebrain
cholinergic cell bodies from axotomy-induced
degeneration and, in contrast to NGF, failed to
increase presynaptic cholinergic function in the
hippocampus. BDNF also failed to protect
dopaminergic neurons after axotomy in the adult
rat brain (Knusel et al., J. Neurosci., in press;
Lapchak and Hefti, NeuroReport 1992; 3: 405).
High levels of BDNF mRNA are found in
cholinergic target areas of the brain such as the
hippocampus. Recent findings suggest that the
expression ofBDNF mRNA in the hippocampus
is regulated by the cholinergic input. We com-
pared the effects of partial and full fimbrial
transections, which result in, respectively, partial
and near-total cholinergic deafferentation on the
expression of BDNF mRNA. Twenty one days
following partial unilateral fimbrial transections
there were significant decreases of BDNF
mRNA expression throughout the hippocampal
formation. The largest decreases were noted in
pyramidal CA1 and CA3 layers and in the den-
tate gyrus. The decreases amounted to 22-36%
reductions compared to unlesioned control
animals. BDNF mRNA levels were decreased to
a greater extent (50-69%) following full uni-
lateral fimbrial transections. Quantitative
Northern blot analysis indicated that hippo-
campal BDNF mRNA was decreased by 29%
and 68%, 3 weeks after partial or full unilateral
fimbrial transections, respectively. The extent of
the reductions in BDNF mRNA levels corre-
lated with reductions in acetylcholinesterase
(ACHE) staining density and cholinergic termi-
nal density determined by quantitative auto-
radiographic analysis of [H]vesamicol binding
sites. In addition, we found that chronic
treatment with atropine (20 mg/kg for 14 days)
decreased BDNF mRNA levels in the pyramidal
CA1, CA2 and CA3 layers and in the dentate
gyrus by 54%. In contrast, chronic treatment
with nicotine (1.18 mg/kg for 14 days), a treat-
ment known to desensitize nicotinic receptors,
did not affect BDNF mRNA expression in the
hippocampal formation. These findings provide
evidence for cholinergic muscarinic regulation of
BDNF mRNA expression in the adult rat
hippocampal formation and suggest the exis-
tence of a tonic stimulation of BDNF synthesis
by the cholinergic afferents.
Besides BDNF, its receptor, trkB, is particu-
larly abundant in the hippocampus. To test the
hypothesis that BDNF may play a role in plas-
ticity, we used defined lesions of perforant path
and fimbria-fornix, two major hippocampal
afferents, alone and in combination, to induce
synaptic rearrangements on granule cell den-
drites of the dentate gyrus. Combined unilateral
lesions of perforant path and fimbria-fornix re-
move afferent connections from entorhinal
cortex and septum and induce sprouting of
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from the contralateral entorhinal cortex into the codes for a truncated trkB mRNA receptor
molecular layer of the hippocampal dentate lacking the cytoplasmic protein kinase domain.
gyrus. The combined fimbria-fornix/perforant These findings suggest that truncated trkB
path lesions did not alter BDNF and trkB
mRNA levels in neuronal layers of the
hippocampus 6-14 days after lesioning. How-
ever, we found that the lesion-induced synaptic
reorganization in the molecular layer of the den-
tate gyrus correlates in time and place with the
induction of trkB mRNA synthesis in non-
molecules expressed on the surface of glial cells
may serve as neurotrophin presenting molecules
to growing axons, thereby permitting synaptic
rearrangement in the central nervous system.
Understanding of regulatory mechanisms of trkB
expression may provide ways to facilitate
regeneration/sprouting in other CNS areas.